198 related articles for article (PubMed ID: 23765377)
1. Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.
Caffarel MM; Chattopadhyay A; Araujo AM; Bauer J; Scarpini CG; Coleman N
J Pathol; 2013 Oct; 231(2):168-79. PubMed ID: 23765377
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.
Winder DM; Chattopadhyay A; Muralidhar B; Bauer J; English WR; Zhang X; Karagavriilidou K; Roberts I; Pett MR; Murphy G; Coleman N
J Pathol; 2011 Nov; 225(3):448-62. PubMed ID: 21952923
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.
Kucia-Tran JA; Tulkki V; Smith S; Scarpini CG; Hughes K; Araujo AM; Yan KY; Botthof J; Pérez-Gómez E; Quintanilla M; Cuschieri K; Caffarel MM; Coleman N
Br J Cancer; 2016 Jul; 115(2):212-22. PubMed ID: 27351213
[TBL] [Abstract][Full Text] [Related]
4. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
5. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.
Ng G; Winder D; Muralidhar B; Gooding E; Roberts I; Pett M; Mukherjee G; Huang J; Coleman N
J Pathol; 2007 Jul; 212(3):325-34. PubMed ID: 17516585
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.
Caffarel MM; Coleman N
J Pathol; 2014 Mar; 232(4):386-90. PubMed ID: 24659184
[TBL] [Abstract][Full Text] [Related]
7. Virus and Host Events in Squamous Carcinogenesis.
Coleman N
Keio J Med; 2016; 65(4):78. PubMed ID: 28025425
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
[TBL] [Abstract][Full Text] [Related]
9. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract][Full Text] [Related]
10. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
[TBL] [Abstract][Full Text] [Related]
11. CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis.
Li Y; Tang Y; Li Z; Hou G; Du X
Arch Biochem Biophys; 2021 Sep; 708():108925. PubMed ID: 34023283
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
13. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin.
Koivisto L; Grenman R; Heino J; Larjava H
Exp Cell Res; 2000 Feb; 255(1):10-7. PubMed ID: 10666329
[TBL] [Abstract][Full Text] [Related]
14. Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study.
Jin T; Lin HX; Lin H; Guo LB; Ge N; Cai XY; Sun R; Chen WK; Li QL; Hu WH
J Transl Med; 2012 Mar; 10():64. PubMed ID: 22458929
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
[TBL] [Abstract][Full Text] [Related]
16. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway.
Guo HB; Lee I; Bryan BT; Pierce M
J Biol Chem; 2005 Mar; 280(9):8332-42. PubMed ID: 15615721
[TBL] [Abstract][Full Text] [Related]
17. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of α5β1-integrin expression in cervical cancer.
Wang HY; Chen Z; Wang ZH; Wang H; Huang LM
Asian Pac J Cancer Prev; 2013; 14(6):3891-5. PubMed ID: 23886203
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.
Tovar-Vidales T; Roque R; Clark AF; Wordinger RJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):622-8. PubMed ID: 18235007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
